A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
Megadott ok: Slow study accrual. Study sponsor decided to terminate the study in consultation with the DSMB.
Key facts
- Where
- Calgary, KanadaSee the site
Where in Kanada
- Arthur J.E. Child Comprehensive Cancer CentreCalgary, KanadaNo longer taking part
Trial details
- Who runs it
- AHS Cancer Control Alberta
- Trial code
- NCT04990895
- Record updated
- 2026. február 5.
- Original description
A single-centre, randomized, 2-arm clinical trial comparing follow-up consisting of tumour-specific Electronic Patient-Reported Outcomes (ePROs) with targeted symptom management versus standard of care follow-up during neoadjuvant/adjuvant systemic therapyRead full original descriptionShow less
A Randomized Clinical Trial of Electronic Tumour-Specific Patient-Reported Outcomes in Early-Stage Breast and Colorectal Cancer Patients Undergoing Neoadjuvant/Adjuvant Chemotherapy
A single-centre, randomized, 2-arm clinical trial comparing follow-up consisting of tumour-specific Electronic Patient-Reported Outcomes (ePROs) with targeted symptom management versus standard of care follow-up during neoadjuvant/adjuvant systemic therapy
Inclusion: Participant has provided informed consent prior to initiation of any study specific activities/procedures; Men or women ≥18 years old newly diagnosed early stage (stage I, II, or III) breast or colorectal cancer who initiate neoadjuvant/adjuvant systemic therapy after curative intent surgery; Participants or their caregivers will need to have a computer and internet access at home and be willing to learn to use and enter data via the web-based portal (REDCap); For the purposes of the current study, fluency and literacy in English will be required.
Exclusion: Early-stage breast or colorectal cancer patients who are not receiving neoadjuvant/adjuvant chemotherapy (patients undergoing adjuvant hormonal or targeted therapy alone without chemotherapy will be excluded); Has known psychiatric or substance abuse disorders that would interfere with compliance with the requirements of the trial; Lack of fluency or literacy of the English language; Lack of access to a computer or internet at home; Inability to complete or enter data on the REDCap system.